Literature DB >> 9720909

The effect of retinoic acid on the activation of the human H19 promoter by a 3' downstream region.

E Kopf1, O Bibi, S Ayesh, M Tykocinski, K Vitner, L H Looijenga, N de Groot, A Hochberg.   

Abstract

The human H19 is paternally imprinted (maternally expressed). It is transcribed by RNA pol II, but has no protein product. Its function is unknown. We showed that the transcription of the human H19 gene is under the simultaneous control of both a 5' upstream (promoter) region and a 3' downstream region in cell lines derived from human choriocarcinomas. Moreover, the activation of the H19 promoter by retinoic acid in cells derived from human testicular germ cell tumors is dependent upon the 3' downstream region. The possibility that the action of retinoic acid on the H19 promoter is an indirect one and involves a member of the AP2 transcription factor family is discussed.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9720909     DOI: 10.1016/s0014-5793(98)00841-2

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  4 in total

Review 1.  Molecular function and regulation of long non-coding RNAs: paradigms with potential roles in cancer.

Authors:  Mohammadreza Hajjari; Atefeh Khoshnevisan; Young Kee Shin
Journal:  Tumour Biol       Date:  2014-09-30

2.  Characterization of human and mouse H19 regulatory sequences.

Authors:  G Banet; O Bibi; I Matouk; S Ayesh; M Laster; K M Kimber; M Tykocinski; N de Groot; A Hochberg; P Ohana
Journal:  Mol Biol Rep       Date:  2000-09       Impact factor: 2.316

3.  Paxillin-dependent regulation of IGF2 and H19 gene cluster expression.

Authors:  Pavel Marášek; Rastislav Dzijak; Irina Studenyak; Jindřiška Fišerová; Lívia Uličná; Petr Novák; Pavel Hozák
Journal:  J Cell Sci       Date:  2015-06-26       Impact factor: 5.285

4.  Telomerase regulation by the long non-coding RNA H19 in human acute promyelocytic leukemia cells.

Authors:  Joëlle El Hajj; Eric Nguyen; Qingyuan Liu; Claire Bouyer; Eric Adriaenssens; George Hilal; Evelyne Ségal-Bendirdjian
Journal:  Mol Cancer       Date:  2018-04-27       Impact factor: 27.401

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.